UHC Continues Refinement of Prior Authorization Policy

The American Physical Therapy Association reported that UnitedHealthcare continues to modify its prior authorization policies for therapy services, including a new framework offering an initial 6-visit or 8-week approval window for new patients. For physician practices and therapy providers navigating UnitedHealthcare's evolving PA requirements, these refinements signal that the payer is responding to pushback — but the devil is in the implementation details.

The ongoing modifications also underscore a persistent challenge: payer PA policies are moving targets, and practices must continuously monitor and adapt to changes that directly affect their clinical workflows and revenue cycle performance.

What Changed

The refined policy establishes a tiered authorization structure for therapy services. New patients may receive an initial authorization of 6 visits within an 8-week window without requiring the full clinical documentation package that was previously demanded upfront. Subsequent visits beyond the initial authorization require additional PA submissions with updated clinical documentation demonstrating ongoing medical necessity and functional progress.

This represents a meaningful adjustment from the original policy rollout, which imposed prior authorization requirements on all therapy visits from the first encounter. The initial policy generated significant opposition from therapy associations, physician groups, and patient advocates who argued that requiring PA for the first therapy visit created barriers to care and contradicted evidence-based therapy protocols.

Why Refinements Create Their Own Complexity

While the 6-visit/8-week initial window reduces the upfront authorization burden, it introduces a new set of operational challenges for practices:

• Visit counting. Practices must accurately track the number of visits used within the initial authorization window and submit continuation requests before the authorization expires. Failing to request continuation in time results in service interruptions or retroactive denials.
• Documentation requirements. Continuation authorizations require updated functional assessments, progress documentation, and revised treatment goals. This documentation must demonstrate measurable improvement or justify why continued therapy is medically necessary despite limited progress.
• Policy version tracking. When payer policies change multiple times in a short period, practices must ensure they are applying the current version of the policy. Staff trained on the original requirements may not be aware of modifications, leading to submission errors.
• Multi-payer complexity. Practices serving patients across multiple UnitedHealthcare plan types (commercial, Medicare Advantage, Medicaid) may face different PA requirements for each product line, even under the same payer umbrella.

The Pattern of Iterative Policy Changes

UnitedHealthcare's therapy PA policy has been modified multiple times since its initial announcement. This iterative approach — announce a broad policy, absorb criticism, refine the policy, absorb more feedback, refine again — has become a common pattern among large payers. It achieves the payer's goal of establishing prior authorization as a requirement for the service category while appearing responsive to provider concerns.

For physician practices, the pattern creates an ongoing operational cost. Each policy revision requires staff retraining, workflow updates, and potentially system configuration changes. The cumulative administrative burden of tracking policy iterations may exceed the burden of the original, simpler policy — even if each individual revision is technically a step in the right direction.

Practical Implications for Practices

Practices managing UnitedHealthcare therapy referrals should take several concrete steps:

Establish a process for monitoring payer policy updates. Assign a specific staff member to track UnitedHealthcare PA policy changes and communicate updates to the clinical and billing teams. Policy changes often take effect quickly and may not be proactively communicated to all affected providers.

Build documentation templates for continuation requests. The clinical documentation required for ongoing therapy authorization follows a predictable structure: baseline functional status, treatment goals, current progress, and justification for continued treatment. Standardizing this documentation reduces the time and effort required for each submission.

Track authorization outcomes by policy version. When PA policies change, practices should measure whether the new version produces different approval rates, denial rates, and appeal outcomes compared to the previous version. This data informs both operational planning and strategic decisions about payer contract negotiations.

The refinements are a response to advocacy and regulatory pressure. They are not the end of the conversation. Practices that stay informed and operationally prepared will navigate the ongoing changes most effectively.